Sarepta Secures $1.15bn From Roche In Ex-US DMD Gene Therapy Deal

 
• By Mandy Jackson
  
International Flags Blowing In Wind_1200x675
Roche will lead SRP-9001 commercialization in all countries outside the US.

More from Deals

More from Business